By generating tool compounds and testing phosphorylation sites in PINK1 and Parkin, the field is getting closer to a molecular understanding of how dysregulation of this pathway could lead to dopaminergic neuron loss in PD or poor mitochondrial clearance in diabetes. Here, PRKN is linked to Parkinson disease.